S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension

BACKGROUND AND OBJECTIVE: Molecular biomarkers are needed to refine prognostication and phenotyping of pulmonary hypertension (PH) patients. S100A12 is an emerging biomarker of various inflammatory diseases. This study aims to determine the prognostic value of S100A12 in PH. METHODS: Exploratory mic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Respirology
Main Authors: TZOUVELEKIS, Argyrios, HERAZO-MAYA, Jose D., RYU, Changwan, CHU, Jen-Hwa, ZHANG, Yingze, GIBSON, Kevin F., ADONTENG-BOATENG, Percy K., LI, Qin, PAN, Hongyi, CHERRY, Benjamin, AHMAD, Ferhaan, FORD, Hubert J., HERZOG, Erica L., KAMINSKI, Naftali, FARES, Wassim H.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047907/
https://ncbi.nlm.nih.gov/pubmed/29611244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/resp.13302
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki